Celsius Therapeutics, Inc. announced it raised $48 Million in an amended filing from an offering of $65 Million

Oct 04, 2019•almost 6 years ago

Amount Raised

$48 Million

CambridgeHealthcare

Company Information

Company

Celsius Therapeutics, Inc.

Location

399 Binney Street

Cambridge, Maryland, United States

About

Celsius Therapeutics is a clinical-stage biotechnology company focused on developing novel medicines in inflammatory disease. Its lead therapeutic candidate is an anti-TREM1 antibody for the treatment of IBD. Celsius is dedicated to pioneering new therapies and is based in Cambridge, Mass.

Related People

Funding Insights

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Celsius Therapeutics, Inc. announced it raised $48 Million in an amended filing from an offering of $65 Million

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Related People

Funding Insights

Company Information